Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00537004 · ClinicalTrials.gov registry record
Language in Primary Progressive Aphasia
A clinical trial of Primary Progressive Aphasia, sponsored by Northwestern University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT00537004: Recruiting study of Primary Progressive Aphasia, sponsored by Northwestern University.
NCT00537004 is a study of Primary Progressive Aphasia that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 500 participants, above the 59-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (747% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00537004, a study of Primary Progressive Aphasia, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to further define the neurological and linguistic deterioration in primary progressive aphasia.
Conditions Studied
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2007-05 |
| Est. Completion | 2027-04 |
What NCT00537004 shows while recruiting
NCT00537004 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 59-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (747% higher).
The record links to 1 condition, with Primary Progressive Aphasia appearing as the primary indexed condition, and to 0 interventions.
NCT00537004 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00537004 about?
NCT00537004 is a clinical study titled "Language in Primary Progressive Aphasia". The purpose of this study is to further define the neurological and linguistic deterioration in primary progressive aphasia.
What is the current status of trial NCT00537004?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2007-05. Estimated completion is 2027-04.
What conditions does trial NCT00537004 study?
This clinical trial studies the following conditions: Primary Progressive Aphasia.
Who is sponsoring clinical trial NCT00537004?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00537004 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Progressive Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00537004's enrollment target sits among peer trials
500 1st of 15 higher than 15 of 15 other Primary Progressive Aphasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Primary Progressive Aphasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
RECRUITING · Phase 4
-
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
RECRUITING
-
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
RECRUITING · Phase 2
-
Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
RECRUITING · Early Phase 1
-
Enhancing Language Function in Aphasia
RECRUITING · NA
-
Enhancing Language Function in Primary Progressive Aphasia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia